BioPharmSignal logoBioPharmSignal

Biotech News

Pulmonx to Participate in Upcoming Investor Conferences

Pulmonx (LUNG)PulmonxCompany update

REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences: Wells Fargo Healthcare

Related news

LUNGPulmonx2026-10-13 20:05 EST

Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026

LUNGPulmonx2026-09-01 20:05 EST

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SENSSenseonics2026-09-10 12:00 EST

Senseonics To Participate in Upcoming Institutional Investor Conferences

DCTHDelcath Systems2026-08-31 20:01 EST

Delcath Systems to Participate in Upcoming Investor Conferences

LMATLeMaitre Vascular2026-08-27 20:51 EST

LeMaitre to Participate at Upcoming Investor Conferences in September

ICUIICU Medical2026-08-27 12:30 EST

ICU Medical to Participate in Upcoming Investor Conferences

PAVMPAVmed2026-08-04 12:30 EST

Lucid Diagnostics to Participate in Upcoming Investor Conferences

MMSIMerit Medical2026-09-04 13:25 EST

Merit Medical to Participate in Upcoming Investors Conferences in September

MMSIMerit Medical2026-08-05 16:00 EST

Merit Medical to Participate in Upcoming Investors Conferences in August

INSMInsmed2026-08-26 11:00 EST

Insmed to Present at September 2026 Investor Conferences

View all latest news

Pulmonx

Minimally Invasive COPD Treatment Pulmonx develops minimally invasive technologies for patients with severe emphysema and chronic obstructive pulmonary disease who remain highly symptomatic despite medical therapy. Zephyr Endobronchial Valve The Zephyr Valve is an implantable bronchoscopic device that occludes selected diseased lung...

Recent company news

LUNGPulmonx2026-10-13 20:05 EST

Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026

LUNGPulmonx2026-09-01 20:05 EST

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LUNGPulmonx2026-08-27 20:05 EST

Pulmonx to Participate in Upcoming Investor Conferences

LUNGPulmonx2026-07-29 20:05 EST

Pulmonx Reports Second Quarter 2026 Financial Results

LUNGPulmonx2026-07-28 20:05 EST

Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference

Stock data

Close
1.76 USD
Market cap
68M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States